Psyched Wellness

Psyched Wellness FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Psyched Wellness (PSYC.CN) as of Oct 26, 2026 is 80.48 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 72.94 % — a change of 10.35% (higher).

FCF Conversion

80.48 %

YoY

10.35%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Psyched Wellness is 2025 80.48 % . FCF Conversion Rate (FCF/EBITDA) of Psyched Wellness was 2024 72.94 % . It decreases by 10.35% higher compared to the previous year.

The Psyched Wellness FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
50.05 CAD
Jan 1, 2019
36.33 CAD
Jan 1, 2020
112.70 CAD
Jan 1, 2021
67.42 CAD
Jan 1, 2022
72.53 CAD
Jan 1, 2023
90.52 CAD
Jan 1, 2024
72.94 CAD
Jan 1, 2025
80.48 CAD
The Psyched Wellness FCF Conversion history
YEARFCF ConversionYoY
80.48 %+10.35%
72.94 %-19.42%
90.52 %+24.80%
72.53 %+7.57%
67.42 %-40.18%
112.70 %+210.21%
36.33 %-27.41%
50.05 %+12,312.78%
0.40 %-98.30%
23.72 %-82.44%
135.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psyched Wellness Stock analysis

What does Psyched Wellness do? Psyched Wellness Ltd. distributes mushroom-derived products and associated consumer packaged goods, focusing on organic, natural, and lab-tested solutions for global health and wellness. The company develops Amanita muscaria-derived water-based extracts, teas, and capsules to reduce stress, ease muscular tension, and promote restorative sleep. Its wholly owned subsidiary, Psyched Wellness Corp, supports these product lines. The firm targets health-conscious consumers seeking natural wellness solutions through its branded offerings. The company's revenue streams come from the sale of mushroom-based supplements and consumer goods, with a focus on Amanita muscaria products for stress relief and sleep enhancement. Psyched Wellness Corp, as the subsidiary, likely handles distribution and product development for the main brand. The primary customer segment consists of individuals prioritizing natural health remedies over conventional pharmaceuticals. Psyched Wellness Ltd. positions itself as a provider of innovative, lab-tested mushroom products, emphasizing organic and natural ingredients. The firm's product range includes water-based extracts, teas, and capsules derived from Amanita muscaria, targeting users interested in stress reduction and improved sleep quality. Sales occur through direct-to-consumer channels for its branded wellness products. Psyched Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psyched Wellness stock

FCF Conversion Rate (FCF/EBITDA) of Psyched Wellness is 80.48 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Psyched Wellness changed from 72.94 % to 80.48 %, representing a 10.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Psyched Wellness since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Psyched Wellness with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Psyched Wellness

All Key Metrics — Psyched Wellness